Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rosuvastatin (20mg) tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹269/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rosumore 20 Tablet contains Rosuvastatin 20 mg, a high-potency statin (HMG-CoA reductase inhibitor) used for effective cholesterol management and cardiovascular risk reduction. Rosuvastatin works by inhibiting the enzyme responsible for cholesterol synthesis in the liver, leading to a significant reduction in low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). The 20 mg strength is considered a high-intensity statin dose, recommended for patients who require aggressive lipid-lowering therapy, such as those with established atherosclerotic cardiovascular disease or diabetes with multiple risk factors. Rosumore 20 not only helps achieve target lipid levels but also plays a critical role in stabilizing atherosclerotic plaques and reducing inflammation within blood vessels, thereby lowering the risk of heart attack, stroke, and other cardiovascular complications. It is generally taken once daily, with or without food, and is known for its strong efficacy and favorable tolerability profile.
Rosumore 20 is generally well tolerated, but some patients may experience side effects such as muscle pain, weakness, headache, nausea, abdominal discomfort, or constipation. Rarely, it may cause serious adverse effects such as myopathy, rhabdomyolysis, or elevated liver enzymes. Regular monitoring of liver function and creatine kinase levels may be recommended in long-term or high-dose therapy. Inform your doctor if you notice symptoms like unexplained muscle pain or yellowing of the eyes or skin.
Rosumore 20 Tablet is indicated for the treatment of hyperlipidemia and mixed dyslipidemia, including familial and non-familial forms. It is also used for the primary and secondary prevention of cardiovascular events in high-risk individuals, such as those with coronary artery disease, diabetes, or a history of myocardial infarction or stroke.
Rosumore 20 Tablet should only be used under medical supervision. It is contraindicated in patients with active liver disease, severe renal impairment, or known hypersensitivity to Rosuvastatin. Alcohol consumption should be limited during therapy to reduce the risk of liver damage. Use during pregnancy and breastfeeding is strictly contraindicated, as statins may harm fetal development. Patients should adhere to a cholesterol-lowering diet and lifestyle along with medication. Routine blood tests to monitor lipid levels and liver enzymes are advised to ensure treatment safety and efficacy.
Store Rosumore 20 Tablet in a cool, dry place below 30°C. Protect from moisture, heat, and direct sunlight. Keep out of reach of children and do not use the medicine after the expiry date mentioned on the packaging.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (5mg) tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 20 mg + Ezetimibe 10 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rosuvastatin 20 mg Tablet is a high-strength statin-class lipid-lowering medicine used for the management of severe hypercholesterolemia, mixed dyslipidemia, and prevention of cardiovascular events such as heart attack and stroke. It works by inhibiting cholesterol production in the liver, making it a widely prescribed cardiovascular segment product by cardiologists and physicians. This ensures strong demand in the PCD pharma franchise and chronic cardiac care market.
Medical distributors and wholesalers benefit from the strong and continuous demand in high-risk cardiovascular patient management. Rosuvastatin 20 mg is commonly used in high-intensity lipid-lowering therapy, ensuring regular repeat prescriptions, stable monthly sales, and consistent movement in both retail and hospital pharmacy channels.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiovascular and lipid-lowering segment, including Rosuvastatin 20 mg Tablet. We provide monopoly rights, quality-assured manufacturing, and consistent supply support to help franchise partners strengthen their position in the chronic cardiac care market.
Wholesalers and stockists benefit from steady prescription-based demand, long-term patient dependency, and strong cardiology usage patterns. As cholesterol management is often part of lifelong therapy, it ensures continuous sales flow, low seasonal variation, and sustainable profitability in pharma distribution.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and lipid management products can contact Cafoli Lifecare for pricing, monopoly franchise rights, and product availability details. We provide complete support including marketing materials, product supply, and territory-based business development assistance.